Form 4 for LIVN LivaNova PLC
Accepted 2025-04-01 00:00:00 ET · period of report 2025-03-30 · accession 0001639691-25-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-01 | 2025-03-30 | LIVN | Bolton Stephanie | Pres, Gbl Epilepsy | F - Tax | $39.13 | -2,835 | 12.8K | -18% | -$110.9K |
| D | 2025-04-01 | 2025-03-30 | LIVN | Bolton Stephanie | Pres, Gbl Epilepsy | M - OptEx | $0.00 | +6,024 | 15.6K | +63% | $0 |
| DM | 2025-04-01 | 2025-03-30 | LIVN | Bolton Stephanie | Pres, Gbl Epilepsy | M - OptEx | $0.00 | -6,024 | 0 | -100% | $0 |
| DM | 2025-04-01 | 2025-03-30 | LIVN | Bolton Stephanie | Pres, Gbl Epilepsy | A - Grant | $0.00 | +36.5K | 15.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-30 | F | D | 2,835 | $39.13 | 12,751 | D | — | — | (F2) Shares withheld to satisfy tax liability. |
| 2 | Common | Ordinary Shares | 2025-03-30 | M | A | 6,024 | $0.00 | 15,586 | D | — | — | (F1) Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. |
| 3 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 457 | $0.00 | 457 | D | — · — to — | 457 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. (F5) On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. |
| 4 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 1,330 | $0.00 | 2,659 | D | — · — to — | 1,330 Ordinary Shares | (F6) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F7) On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 5 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 1,229 | $0.00 | 3,686 | D | — · — to — | 1,229 Ordinary Shares | (F6) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F8) On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 6 | Derivative | Performance Stock Units | 2025-03-30 | M | D | 805 | $0.00 | 0 | D | — · — to — | 805 Ordinary Shares | (F9) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement. (F10) On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired. |
| 7 | Derivative | Performance Stock Units | 2025-03-30 | M | D | 717 | $0.00 | 0 | D | — · — to — | 717 Ordinary Shares | (F9) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement. (F11) On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's Return on Investment Capital (ROIC) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The performance achieved was 78.5%, and the actual number of vested shares is presented as the quantity that was acquired. |
| 8 | Derivative | Performance Stock Units | 2025-03-30 | A | A | 7,027 | $0.00 | 7,027 | D | — · — to — | 7,027 Ordinary Shares | (F14) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. (F17) On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's TSR for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. |
| 9 | Derivative | Restricted Stock Units | 2025-03-30 | A | A | 7,027 | $0.00 | 7,027 | D | — · — to — | 7,027 Ordinary Shares | (F6) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F13) On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 10 | Derivative | Performance Stock Units | 2025-03-30 | A | A | 3,513 | $0.00 | 3,513 | D | — · — to — | 3,513 Ordinary Shares | (F14) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. (F15) On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's FCF for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. |
| 11 | Derivative | Performance Stock Units | 2025-03-30 | A | A | 3,513 | $0.00 | 3,513 | D | — · — to — | 3,513 Ordinary Shares | (F14) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. (F16) On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's ROIC calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. |
| 12 | Derivative | Stock Appreciation Rights | 2025-03-30 | A | A | 15,385 | $0.00 | 15,385 | D | $39.13 · — to 2035-03-30 | 15,385 Ordinary Shares | (F18) On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. |
| 13 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 426 | $0.00 | 0 | D | — · — to — | 426 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. (F4) On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. |
| 14 | Derivative | Performance Stock Units | 2025-03-30 | M | D | 1,060 | $0.00 | 0 | D | — · — to — | 1,060 Ordinary Shares | (F9) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement. (F12) On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 58%, and the actual number of vested shares is presented as the quantity that was acquired. |